⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

VRTX

Vertex Pharmaceuticals Incorporated

Healthcare · Biotechnology

521.12USD

-7.7800 (-1.47%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 521.12
P/E30.0
Dvd Ind Yld—
P/B6.52
P/S10.5
Curr EV/T12M EBITDA25.6
Mkt Cap (USD)132.1B
Curr EV (USD)128.2B
2)

Per Share Data

EPS T12M17.15
DPS—
Bk Val Per Sh79.92
Rev/Sh49.32
Cash/Sh30.98
Curr Shares Out253.5M
FCF/Sh14.88
3)

Cash Flow Analysis

P/CF30.8
Curr P/FCF34.8
CF/NI1.0
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales34.1%
Eff Interest Rate0.7%
4)

Growth Potential

Dil EPS 1Y Gr836.5%
Cap 1Y Gr13.7%
BPS 1Y Gr13.7%
R&D To Sales25.4%
Retention Rate100.0%
Rev 1Y Gr8.9%
FCF 1Y Gr504.1%
Assets 1Y Gr13.8%
5)

Profitability

EBITDA5.0B
EBIT4.8B
Operating Margin38.0%
Pretax Margin41.9%
Net Margin35.0%
ROA17.1%
ROE23.5%
ROC18.0%
Asset Turnover0.49
6)

Structure

Current Ratio3.19
Quick Ratio2.54
Debt/Assets7.2%
Debt/Com Eq9.8%
Net Debt/EBITDA-0.83
Tot Debt/Capital8.9%
Gross Margin86.0%
EBIT/Int Exp359.2

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.